| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.58 | 0.04 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |